US14280C1053
US14280C1053
Carlsmed, Inc.
Loading chart...
Company Profile
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Latest News

PR Newswire • 10/06/2026
Avance Appoints Carl Stanton as Senior Partner
Investing.com • 10/05/2026
Goldman cuts Carl Zeiss Meditec as ‘valuation disconnected from fundamentals’

GlobeNewswire • 10/02/2026
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ACCESS Newswire • 10/01/2026
Top Realtor in Hood River County, OR: Carl Blakeslee & Shay Ryan-Blakeslee

GlobeNewswire • 10/01/2026
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
Company Profile
5
MetricsCountry
Region
Sector
Industry
Website
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections